US Patent Issued to CELLARTGEN on Feb. 3 for "Microfluidic device for cerebrovascular simulation and high-efficiency blood-brain barrier simulation system comprising same" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,297, issued on Feb. 3, was assigned to CELLARTGEN INC. (Seoul, South Korea).

"Microfluidic device for cerebrovascular simulation and high-efficiency blood-brain barrier simulation system comprising same" was invented by Seung Woo Cho (Seoul, South Korea), Yong Sun Bahn (Seoul, South Korea), Jin Kim (Seoul, South Korea) and Kyung Tae Lee (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides a microfluidic device for simulating a blood-brain barrier and a blood-brain barrier simulation system including the same, and the microfluidic device includes: a first channel; a second channel which is adjacently conne...